Abstract
The aim of this study was to examine the effect of growth conditions on slime production by Staphylococcus aureus clinical isolates. The addition of glucose to the medium enhanced slime production in the majority of Staphylococcus aureus isolates cultured from infections associated with orthopaedic prostheses. Iron limitation also stimulated this ability even in the absence of the additional carbohydrate source. Staphylococcus aureus isolates were classified as Group 1 [strains producing slime only in trypticase soy broth supplemented with 1% glucose (TSBG) or in iron-limited trypticase soy broth (TSB/Fe-)]; Group 2 (slime + only in TSB/Fe-); or Group 3 (slime + only in TSBG). Seven repeatedly slime-negative strains were stimulated to produce slime by subpassaging in iron-limited medium. Low iron levels, usually found in vivo, could stimulate slime production by Staphylococcus aureus and support chronic infections associated with orthopaedic prostheses.
| Original language | English |
|---|---|
| Pages (from-to) | 343-345 |
| Number of pages | 3 |
| Journal | European Journal of Clinical Microbiology and Infectious Diseases |
| Volume | 20 |
| Issue number | 5 |
| Publication status | Published - 2001 |
Fingerprint
ASJC Scopus subject areas
- Microbiology (medical)
- Immunology
Cite this
Effect of iron limitation on slime production by Staphylococcus aureus. / Baldassarri, L.; Bertuccini, L.; Ammendolia, M. G.; Arciola, C. R.; Montanaro, L.
In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, No. 5, 2001, p. 343-345.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effect of iron limitation on slime production by Staphylococcus aureus
AU - Baldassarri, L.
AU - Bertuccini, L.
AU - Ammendolia, M. G.
AU - Arciola, C. R.
AU - Montanaro, L.
PY - 2001
Y1 - 2001
N2 - The aim of this study was to examine the effect of growth conditions on slime production by Staphylococcus aureus clinical isolates. The addition of glucose to the medium enhanced slime production in the majority of Staphylococcus aureus isolates cultured from infections associated with orthopaedic prostheses. Iron limitation also stimulated this ability even in the absence of the additional carbohydrate source. Staphylococcus aureus isolates were classified as Group 1 [strains producing slime only in trypticase soy broth supplemented with 1% glucose (TSBG) or in iron-limited trypticase soy broth (TSB/Fe-)]; Group 2 (slime + only in TSB/Fe-); or Group 3 (slime + only in TSBG). Seven repeatedly slime-negative strains were stimulated to produce slime by subpassaging in iron-limited medium. Low iron levels, usually found in vivo, could stimulate slime production by Staphylococcus aureus and support chronic infections associated with orthopaedic prostheses.
AB - The aim of this study was to examine the effect of growth conditions on slime production by Staphylococcus aureus clinical isolates. The addition of glucose to the medium enhanced slime production in the majority of Staphylococcus aureus isolates cultured from infections associated with orthopaedic prostheses. Iron limitation also stimulated this ability even in the absence of the additional carbohydrate source. Staphylococcus aureus isolates were classified as Group 1 [strains producing slime only in trypticase soy broth supplemented with 1% glucose (TSBG) or in iron-limited trypticase soy broth (TSB/Fe-)]; Group 2 (slime + only in TSB/Fe-); or Group 3 (slime + only in TSBG). Seven repeatedly slime-negative strains were stimulated to produce slime by subpassaging in iron-limited medium. Low iron levels, usually found in vivo, could stimulate slime production by Staphylococcus aureus and support chronic infections associated with orthopaedic prostheses.
UR - http://www.scopus.com/inward/record.url?scp=0034750804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034750804&partnerID=8YFLogxK
M3 - Article
VL - 20
SP - 343
EP - 345
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
SN - 0934-9723
IS - 5
ER -